Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
      • ICDDTM’25 2025 Gallery
      • Past Events Gallery
    • The Venue
      • The Venue
      • Nearby Hotels
      • Nearby Tourist Attractions
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Conducting Clinical Trials



This workshop provides a focused and practical overview of essential elements required for initiating clinical trials. The session will cover three key areas:

a) Preclinical data requirements for clinical trial applications,
b) The different categories of clinical trials, and
c) Common myths and pitfalls that may hinder trial integrity and execution.

Participants will gain practical insights into study planning, and real-world challenges in clinical trial implementation. This workshop is ideal for investigators, sponsors, and research teams aiming to enhance their trial readiness and conduct high-quality research.

Max no of participants: Unlimited
Venue: Mini Auditorium, HSAAS UPM

TENTATIVE PROGRAMME SCHEDULE

Time
Session Title
Speaker / Facilitator
09:00 – 10:00

Session 1: Preclinical Data Requirements for Clinical Trial 

• Key preclinical studies: pharmacology, toxicology, and PK/PD  
• Translating nonclinical data into human safety profiles
Dr Sharon Ng Shi Min
Clinical Pharmacologist,
Centre for Clinical Trials,
Hospital Ampang
10:00 – 11:00

Session 2: Understanding the Different Categories of Clinical Trials 

• Overview of Phase I–IV, BA/BE, and IITs  
• Distinction between exploratory and confirmatory trials  
• Distinction based on objectives (superiority, equivalence, etc)
Mr Chew Chun Keat
Technical Head  
Centre for Clinical Trials, 
Institute for Clinical Research,
Hospital Ampang
11:00 – 11:15
Break
11:15 – 12:00

Session 3: Common Myths and Pitfalls in Clinical Trials

• Misconceptions about approvals, timelines, and oversight  
• Frequent protocol deviations and documentation issues  
• Building a culture of compliance and quality
Ms Cheah Kit Yee 
Clinical Trial Pharmacist, 
Centre for Clinical Trials,
Hospital Ampang
12:00 – 13:00

Interactive Panel Discussion: From Ideas to Implementation – What’s Needed to Conduct a Clinical Trial? 

This interactive session invites participants to share their own study concepts or research interests.  Together with the panel, they will explore the necessary steps, designs, approvals, and resources required to transform an idea into a clinical trial proposal.
All Speakers

EXPECTED OUTCOMES

Participants will: 

  • Understand how preclinical findings support clinical trial. 
  • Be able to identify the right category and design for their study. 
  • Recognize and avoid common pitfalls in planning and operations.
  • Gain hands-on guidance on how to turn a research idea into a viable clinical trial.

REQUEST FROM PARTICIPANTS

Ready with research ideas/ synopsis covering:

Title:PICO
Study Population:
Intervention:
Comparator:
Outcome:
Objectives:
Primary Objective:
Secondary Objective:
Study Endpoints: 
Efficacy:  
Safety:
Methodology:  
Study design
Sample size:
Duration of study:
Statistical Methods:

SPEAKERS

Mr Chew Chun Keat
Technical Head

Mr Chew Chun Keat (CK) is the Technical Head at the Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, and a Fellow at the International Vaccine Institute. He played a key role in establishing one of Malaysia’s two NPRA-accredited First-in-Human (FIH) trial centers at Hospital Ampang. The centre has since led and conducted numerous trials, including bioavailability, bioequivalence, vaccine efficacy, drug delivery systems, and drug-drug/food-drug interaction studies.

CK is a board member of the Medical Research and Ethics Committee (MREC) under the Ministry of Health. He also contributed to the enhancement of pharmacovigilance oversight in clinical trials through the development of an online platform for reporting Serious Adverse Events (SAE) and Suspected Unexpected Serious Adverse Reactions (SUSAR).

He actively supports the World Health Organization (WHO) in alignment with the World Health Assembly’s direction on strengthening national and regional clinical trial ecosystems. He has served on expert panels and working groups involved in the development of key national guidelines, including the Malaysian Guideline for Phase 1 Unit Inspection & Accreditation Programme, Malaysian Phase 1 Clinical Trial Guideline, and A Guide to Conducting Clinical Trials in Malaysia.

Ms Cheah Kit Yee
Clinical Trial Pharmacist

Cheah Kit Yee is a Clinical Trial Pharmacist at the Centre for Clinical Trial (CCT), Institute for Clinical Research, Ministry of Health Malaysia. She holds an MPharm from the University of Strathclyde and has nine years of experience in clinical trial operations.

She has coordinated and managed over ten bioavailability and bioequivalence (BABE) studies, as well as drug-drug interaction (DDI) and bioavailability (BA) trials. Her responsibilities include ethics and regulatory submissions and ensuring that trials are conducted in accordance with approved protocols and timelines. In her role as a Clinical Trial Pharmacist, she oversees investigational product (IP) management—including receipt, storage, preparation, dispensing, accountability, and reconciliation—across more than 20 clinical trials, including Phase III studies involving vaccines and haematological products.

She is also involved in reviewing and maintaining CCT’s standard operating procedures (SOPs) and supports regulatory inspections to uphold the unit’s accreditation under NPRA’s Bioequivalence Centre Compliance and Phase 1 Unit Accreditation Programmes. As part of her current role, she also serves as a member of the Medical Research and Ethics Committee (MREC), supporting the ethical oversight of clinical research.

Dr Sharon Ng Shi Min
Clinical Pharmacologist

Dr. Sharon Ng completed her Masters in Clinical Pharmacology in 2021 with distinction from King’s College London. She has been working in the Clinical Research Ward, Hospital Ampang for the past 11 years and is an experienced clinical investigator who specializes in healthy volunteer research.

She has been the principal or co-investigator in many clinical trials over the years. She also provides consultation on early phase clinical trials and is involved in protocol development and clinical trial conduct. She won Clinical Research Malaysia’s Sponsored Research Award for “Top Recruiter” in 2023.



Click here to view all the other Pre-Conference Workshops >>

Click here to view the main Programme Schedule >>

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Click the image to download the PDF. To save the image, right-click on it and select "Save As."

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Dhaka University, Bangladesh)
(Fakultas Kedokteran, Universitas Diponegoro, Indonesia)

Platinum Sponsor

Exhibitors

Other Sponsors

© 2026 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Powered by Minimalist Blog WordPress Theme